DAX25.289 +0,5%Est506.162 -0,2%MSCI World4.343 -0,1%Top 10 Crypto8,6000 -1,4%Nas22.878 -1,2%Bitcoin57.042 -0,2%Euro1,1805 +0,1%Öl70,70 -0,3%Gold5.190 +0,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 Deutsche Telekom 555750 Novo Nordisk A3EU6F Siemens Energy ENER6Y SAP 716460 Allianz 840400 freenet A0Z2ZZ DroneShield A2DMAA Infineon 623100 Gerresheimer A0LD6E Microsoft 870747 Bayer BAY001 Lufthansa 823212 Amazon 906866
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Zahlenflut: DAX schließt moderat höher -- US-Börsen uneinheitlich -- NVIDIA: Rekordzahlen -- Auftragsrekord bei HENSOLDT -- Bitcoin, D-Wave, Nutanix, AMD, Siemens Energy, Salesforce im Fokus
Top News
Greenlight Capital-Portfolio: In diese Aktien investierte David Einhorn im vierten Quartal 2025 Greenlight Capital-Portfolio: In diese Aktien investierte David Einhorn im vierten Quartal 2025
Tesla-Aktie vor Bewährungsprobe: Wieso Robotaxis zum Problem werden könnten Tesla-Aktie vor Bewährungsprobe: Wieso Robotaxis zum Problem werden könnten
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Delcath Systems Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
7,70 EUR -0,85 EUR -9,94 %
BMN
9,18 USD +0,16 USD +1,77 %
nachbörslich
BTT
Delcath Systems jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.305,53 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PT5P

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS24661P8077

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolDCTH

Delcath Systems Aktien News

DatumMeistgelesen
PR NewswireDelcath Systems Reports First Quarter 2024 Results and Business Highlights
PR NewswireDelcath Systems to Host First Quarter 2024 Earnings Call
PR NewswirePublication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT
Wer­bungDelcath Systems-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireDelcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireDelcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireDelcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
PR NewswireDelcath Systems Closes $7 Million Private Placement
PR NewswireDelcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call
PR NewswireDelcath Systems Appoints Martha S. Rook as Chief Operating Officer
PR NewswireDelcath Systems Announces $7 Million Private Placement
PR NewswireDelcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireDelcath Systems to Participate in Upcoming Investor Conferences
PR NewswireDelcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System)
PR NewswireDelcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireDelcath Systems Receives Permanent J-Code (J9248) for HEPZATO™ (melphalan/Hepatic Delivery System) Effective April 1, 2024
PR NewswireDelcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
PR NewswireDelcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT™
PR NewswireDelcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireDelcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research
PR NewswireDelcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireDelcath Systems Reports Third Quarter 2023 Results and Provides Business Update
PR NewswireDelcath Systems to Host Third Quarter 2023 Results Call
PR NewswireDelcath Systems Announces a Comparative Study of Chemosat and SIRT Published in the Journal Cancers
PR NewswireDelcath Systems to Participate in the Lytham Partners Fall 2023 Investor Conference
PR NewswireDelcath Systems to Participate at the Roth MKM 2023 Healthcare Opportunities Conference on October 12, 2023
PR NewswireDelcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireA Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting
PR NewswireDelcath Systems to Participate at the H.C. Wainwright 25th Annual Investor Conference on September 12 and 13, 2023
PR NewswireDelcath Systems, Inc. Announces Additional $35 Million in Funding Tied to the FDA Approval of HEPZATO KIT™
PR NewswireDelcath Systems Announces an Independent Investigator Presentation at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting
PR NewswireDelcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
PR NewswireDelcath Systems Reports Second Quarter 2023 Results and Provides Business Update
PR NewswireDelcath Systems to File Its Second Quarter 2023 10-Q the Week of August 7 and Expects to Host a Conference Call the Following Week
PR NewswireDelcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireDelcath Systems Appoints Vojislav Vukovic as Chief Medical Officer
PR NewswireDelcath Systems Announces Sandra Pennell as Senior Vice President of Finance
PR NewswireDelcath Systems Provides Business Update and Reports Preliminary First Quarter 2023 Financial Results
PR NewswireDelcath Systems to Participate in the Lytham Partners Spring 2023 Investor Conference
PR NewswireDelcath Systems to Host First Quarter 2023 Results
PR NewswireDelcath Systems Announces Resumption of Interest-Only Period for Company's Debt Facility

Delcath Systems News

Delcath Systems News: auf dieser Seite finden Sie alle Delcath Systems News und Nachrichten zur Delcath Systems Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Delcath Systems News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Delcath Systems News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.